Page last updated: 2024-11-02

pentamidine and Libman-Sacks Disease

pentamidine has been researched along with Libman-Sacks Disease in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Villamil-Gómez, WE1
Calderón-Gomezcaseres, Á1
Rodriguez-Morales, AJ1
Izquierdo Patrón, M1
Lafuente, C1
Haro Estarriol, M1
Arévalo González, M1

Reviews

1 review available for pentamidine and Libman-Sacks Disease

ArticleYear
[Sinus bradycardia secondary to systemic pentamidine].
    Revista espanola de cardiologia, 1996, Volume: 49, Issue:12

    Topics: Bradycardia; Chronic Disease; Female; HIV Seronegativity; Humans; Injections, Intravenous; Lupus Ery

1996

Other Studies

1 other study available for pentamidine and Libman-Sacks Disease

ArticleYear
Visceral leishmaniasis in a patient with systemic lupus erythematosus from Colombia, Latin America.
    Le infezioni in medicina, 2019, Mar-01, Volume: 27, Issue:1

    Topics: Adult; Antiprotozoal Agents; Colombia; Humans; Leishmaniasis, Visceral; Lupus Erythematosus, Systemi

2019